Carcinogenic effects of low-level ionizing radiation: Problems and prospects

In Vivo

Volumn 16, Issue 6, 2002, Pages 527-533

  Upton, Arthur C ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Adaptive response; Cancer; Carcinogenesis; Chromosome aberration; DNA damage; Dose response; Mutation; Radiation; Threshold

Indexed keywords

AGE; BREAST CANCER; CANCER MODEL; CANCER RESEARCH; CANCER RISK; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; DNA DAMAGE; DNA REPAIR; EVIDENCE BASED MEDICINE; GENETIC DISORDER; GENETIC RISK; HUMAN; HYPOTHESIS; IN VITRO STUDY; IN VIVO STUDY; IONIZING RADIATION; LABORATORY TEST; LOW ENERGY RADIATION; LUNG CANCER; MEDICAL ASSESSMENT; MOUSE STRAIN; NONHUMAN; OSTEOSARCOMA; PUBLIC HEALTH; RADIATION CARCINOGENESIS; RADIATION DOSE; RADIATION EXPOSURE; RADIATION MUTAGENESIS; REVIEW; SEX; TESTIS CANCER; THYROID CANCER; ADAPTATION; ANIMAL; MUTATION; RADIATION INJURY; RADIATION RESPONSE; RISK ASSESSMENT; STATISTICAL MODEL;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; DNA DAMAGE; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LINEAR MODELS; MUTATION; NEOPLASMS, RADIATION-INDUCED; RADIATION TOLERANCE; RADIATION, IONIZING; RISK ASSESSMENT;

EID: 0036861315     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (96)

1. U.S. Environmental Protection Agency: Risk Assessment Guidelines of 1986. EPA600/8-87/045. Washington, D.C., U.S. Environmental Protection Agency, Office of Health and Environmental Assessment, 1987.
2. International Commission on Radiological Protection (ICRP): 1990 Recommendations of the international commission on radiological protection. ICRP Publication 60, Ann. ICRP 21 (1-3): 1-201; 1991.
3. National Council on Radiation Protection and Measurements (NCRP): Risks Estimates for Radiation Protection. NCRP Report No. 115. Bethesda, National Council on Radiation Protection and Measurements; 1993.
4. National Council on Radiation Protection and Measurements (NCRP): Uncertainties in Fatal Risk Estimates Used in Radiation Protection. NCRP Report No. 126. Bethesda, National Council on Radiation Protection and Measurements; 1997.
5. National Council on Radiation Protection and Measurements (NCRP): Evaluation of the Linear-Nonthreshold Dose-Response Model for Ionizing Radiation. NCRP Report No. 136. Bethesda, National Council on Radiation Protection and Measurements; 2001.
6. Pollycove M.: The issue of the decade: Hormesis. Eur J Nucl Med 22: 399-401, 1995.
7. Mossman KL: The linear no-threshold debate: Where do we go from here? Medical Physics 25: 279-286, 1998.
8. Bremer DJ and Raabe OG: Topics under debate: Is the linear-no-threshold hypothesis appropriate for use in radiation protection? Radiat Protect Dosim 97: 279-285, 2001.
9. Lacassagne A: Les Cancers Produit Par Les Rayonnements Électromagnétiques. Actualités Scientifiques et Industrielles, No. 975, Paris, Hermann & Cie, 1945.
10. Furth J and Lorenz E: Carcinogenesis by ionizing radiations, In: Radiation Biology, edited by A. Hollaender, New York, McGraw-Hill, 1954, pp. 1145-1201.
11. Shimkin MB and Triolo VA: History of chemical carcinogenesis: Some prospective remarks. Proc Exp Tumor Res 11: 1-20, 1969.
12. Peto R, Gray R, Bantom P and Grasso P: Effects on 4080 rats of chronic ingestion of N-nitrosodiethylamine or N-nitrosodimethyl-amine: A detailed dose-response study. Cancer Res 23 (Part 2): 6415-6451, 1991.
13. Zeise L, Wilson R and Crouch EAC: Dose-response relationships for carcinogenesis: A review. Env Health Perspect 73: 259-308, 1987.
14. Upton AC: The question of thresholds for radiation and chemical carcinogenesis. Cancer Investigation 7: 267-276, 1989.
15. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR): Sources and Effects of Ionizing Radiation. Report to the General Assembly, with Annexes. New York, United Nations; 2000.
16. Pierce DA and Mendelsohn ML: A model for radiation-related cancer suggested by atomic bombm survivor data. Radiation Research 152: 642-654, 1999.
17. Luckey TD: Radiation hormesis in cancer mortality. Internat J Occup Med Toxicol 3: 175-191; 1994.
18. Wojcik A: The current status of the adaptive response to ionizing radiation in mammalian cells. Human and Ecol Risk Assessment 6: 281-300, 2000.
19. Calabrese EJ and Baldwin LA: U-shaped dose-responses in biology, toxicology, and public health. Ann Rev Public Health 22: 15-33, 2001.
20. Calabrese EJ and Baldwin LA: Radiation hormesis: The demise of a legitimate hypothesis. BELLE Newsletter 8: 38-46, 1999.
21. Hanahan D and Weinberg RA: The hallmarks of cancer. Cell 100: 57-70, 2000.
22. Little JB: Radiation carcinogenesis. Carcinogenesis 21: 397-404, 2000.
23. Goodhead DT: Spatial and temporal distribution of energy. Health Phys 55: 231-240, 1988.
24. Goodhead DT: Initial events in the cellular effects of ionizing radiations: Clustered damage in DNA. Int J Rad Biol 65: 7-17, 1994.
25. Brenner JD and Ward J: Restraints on energy deposition/target size of multiply damaged sites associated with DNA DSB. In: Hagen U, Jung H, Streffler C, eds. Radiation Research 1895-1995. Proceedings of the Tenth International Congress of Radiation Research 1995: 443-446.
26. Mothersill C and Seymour C: Radiation-induced bystander effects: Past history and future directions. Radia Res 155: 759-767, 2001.
27. Ward JF: Radiation mutagenesis: The DNA lesions responsible. Radiat Res 142: 362-368, 1995.
28. Le XC, Xing JZ, Lee J, Leadon SA and Weinfeld M: Inducible repair of thymic glycol detected by an ultrasensitive assay for DNA damage. Science 280: 1066-1069, 1998.
29. Vilenchik MM and Knudson AG Jr: Inverse radiation dose-rate effects on somatic and germ-line mutations and DNA damage rats. Proc Natl Acad Sci USA 97: 53 81-53 86, 2000.
30. Nicholson DW and Thomberry NA: Caspases: Killer proteinases. Trends in Biol Sci 22: 299-306, 1997.
31. Sankaranarayanan K: Ionizing radiation, genetic risk estimation, and molecular biology: Impact and inferences. Trends Genet 9: 79-84, 1993.
32. United Nations Scientific Communittee on the Effects of Atomic Radiation (UNSCEAR): Sources and Effects of Ionizing Radiation. Report to the General Assembly with Annexes. New York, United Nations; 1993.
33. Nasagawa H and Little JB: Unexpected sensitivity to the induction of mutations by very low doses of alpha-particle radiation: Evidence for a bystander effect. Radiat Res 152: 552-557, 1999.
34. Sanderson BJS and Morely AA: Exposure of human lymphocytes to ionizing radiation reduces mutagenesis induced by subsequent ionizing radiation. Mutation Res 164: 347-351, 1986.
35. Kelsey KT, Memisoglu A, Frenkel D and Liber HL: Human lymphocytes exposed to low doses of X-rays are less susceptible to radiation-induced mutagenesis. Mutation Res 263: 197-2001, 1991.
36. Rigaud O, Laquerbe A and Moustacchi E: Decreased deletion-type mutation in radioadapted human cells. Radiat Res 133: 94-101, 1993.
37. Zhou PK, Zhiang XQ, Sun WZ, Liu XY, Zhiang YP and Wei K: Adaptive response to mutagenesis and its molecular basis in a human T-cell leukemia line primed with a low dose of gamma rays. Radiat Envir Biophys 33: 211-217, 1994.
38. Sasaki MS: On the reaction kinetics of the radioadaptive response in cultured mouse cells. Int J Rad Biol 68: 281-291, 1995.
39. Brewen JG, Preston RJ, Jones KP and Gosslee DG: Genetic hazards of ionizing radiation: Cytogenetic extrapolations from mouse to man. Mutat Res 17: 245-254, 1973.
40. Morgan WF, Day JP, Kaplan MI, McGhee EM and Limoli CL: Genomic instability induced by ionizing radiation. Radiat Res 146: 247-258, 1996.
41. Gaulden ME and Read CB: Linear response of acentric chromosome fragments down to 1 R of X-rays in grasshopper neuroblasts, a potential mutagen-test system. Mutation Res 49: 55-60, 1978.
42. Lloyd DC and Purrott RJ: Chromosome aberration analysis in radiological protection dosimetry. Radiat Protect Dosim-L 1: 19-28, 1981.
43. Pohl-Rüling J and Land Fischer P: Chromosome aberrations in inhabitants of areas with elevated natural radioactivity. In: Radiation-Induced Chromosome Damage in Man. Ishihara T, Sasaki MS, eds. New York, Alan Liss, 1983: pp.527-560.
44. Bender MA, Awa AA, Brooks AL, Evans HJ, Groer PG, Littlefield LG, Pereira C, Preston RJ and Wachholz BW: Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutation Res 196: 103-159, 1988.
45. Wang JX, Boice JD Jr, Wei LX, Beebe GW, Zha YR, Kaplan MM, Tao ZF, Maxon HR III, Zhang S, Schneider AB, Tan B, Wesseler TA, Chen D, Ershow AG, Kleinerman KA, Littlefield LG and Preston D: Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Nat Ca Inst 82: 478-485, 1990.
46. United Nations Scientific Communittee on the Effects of Atomic Radiation (UNSCEAR): Sources and- Effects of Ionizing Radiation. Report to the General Assembly, with Annexes. New York, United Nations, 1994.
47. Vijayalaxmi and Evans HJ: Measurement of spontaneous and X-irradiation-induced 6-thioguanine-resistant human blood lymphocytes using a T-cell cloning technique. Mutation Res 125: 87-94, 1984.
48. Wolff S: Aspects of the adaptive response to very low doses of radiation and other agents. Mutation Res 358: 135-142, 1996.
49. Shadley JD and Weincke JK: Induction of adaptive response by X-rays is dependent on radiation intensity. Int J Rad Biol 56: 107-118, 1989.
50. Cox R and Little JB: Oncologic cell transformation in vitro. Adv Radiat Biol 16: 137-155, 1992.
51. Mendonca MS, Howard K, Fasching CL, Farrington DL, Desmond SA, Standbridge EJ and Redpath JL: Loss of suppressor loci on chromosomes 11 and 14 may be required for radiation-induced neoplastic transformation of HeLa x sking human cell hybrids. Radiat Res 149: 246-255, 1998.
52. Siggs M, Crompton NEA and Burkhart W: Enhanced neoplastic transformation in an inhomogeneous, radiation field: An effect of the presence of heavily damaged cells. Radiat Res 148: 543-547, 1997.
53. Hei TK, Wu L-J, Liu S-X, Vannais D, Waldren CA and Randers-Pherson G: Mutagenic effects of a single and an exact number of alpha particles in mammalian cells. Proc Natl Acad Sci USA 94: 3765-3770.
54. Azzam EI, DeToledo SM, Raaphorst GP and Mitchell REJ: Low-dose ionizing radiation decreases the frequency of neoplastic transformation to a level below the spontaneous rate in C3H10T1/2 cells. Radiat Res 146: 3 69-3 73, 1996.
55. Miller RC, Geard RC, Geard MJ and Hall EJ: Rapid communication. Cell cycle-dependent radiation-induced oncogenic transformation of C3H10T1/2 cells. Radiat Res 130: 129-130, 1992.
56. 137Cs γ-rays of cells in the G2M-phase age interval. Int J Rad Biol 62: 191-199, 1992.
57. Cao J, Wells RL and Elkind MM: Neoplastic transformation of CC3H10T1/2 mouse embryo cells: Cell cycle dependence for 50 kV X-rays and UVB light. Int J Rad Biol 64: 83-92, 1993.
58. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR): Genetic and Somatic Effects of Ionizing Radiation. Report to the General Assembly with Annexes. New York, United Nations, 1986.
59. Upton AC, Albert RE, Bums FJ and Shore RE. eds: Radiation Carcinogenesis. New York, Elsevier, 1986.
60. Raabe OG, Rosenblatt LS and Schlencker RA: Interspecies scaling of risks for radiation-induced bone cancer. Int J Rad Biol 57: 1047-1061, 1990.
61. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR): Ionizing Radiation: Sources and Biological Effects. Report to the General Assembly, with Annexes. New York, United Nations, 1982.
62. Sacher GA: The Gompertz transformation in the study of the injury-mortality relationship: Application to late radiation effects and aging. In: Radiation & Aging. Lindop PJ and Sacher GA, eds. London, Taylor & Francis, 1966: 411-441.
63. Mulcahy RT, Gould MN and Clifton KH: Radiogenic initiation of thyroid cancer. A common cellular event. Int J Rad Biol 45: 419-426, 1984.
64. Cliflon KH, Tanner MA and Gould MN: Assessment of radiogenic cancer induction frequency per clonogenic rat mammary cell in vivo. Cancer Res 46: 2390-2395, 1986.
65. Kamiya K, Yasukawa-Barnes J, Mitchen JM, Gould MN and Clifton KH: Evidence that carcinogenesis involves an imbalance between epigenetic high frequency initiation and suppression of promotion. Proc Natl Acad Sci USA 92: 1332-1336, 1995.
66. Ponnaiya B, Comforth MN and Ullrich RL: Radiation-induced chromosomal instability in BALB/c and C57/BL mice: The difference is as clear as black and white. Radiat Res 147: 121-125, 1997.
67. Hino O, Klein-Szanto JP, Freed JJ, Testa JR, Brown DQ, Vilensky M, Young RS, Tartoff KD and Knudson AG: Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc Natl Acad Sci USA 90: 327-331, 1993.
68. Bennett LM, Haugen-Strano A, Cochran C, Brownlee HA, Fiedorek FT and Wiseman RW: Isolation of the mouse homologue of BRCA I and genetic mapping to mouse chromosome 11. Genomics 29: 576-581, 1995.
69. Barlow C, Hirotsune S, Paylor R, Liyanage M, Eckhaus M, Collins F, Shiloh Y, Crawley JN, Ried T, Tagle D and Wynshaw-Boris A: Atm-deficient mice: A paradigm of ataxia telangiectasia. Cell 86: 159-171, 1996.
70. Reitmair AH, Redston M, Cai JC, Chuang TC, Bjerknes M, Cheng H, Hay K, Gallinger S, Bapat B and Mak TW: Spontaneous intestinal and skin neoplasms in Msh2-deficient mice. Cancer Res 56: 3842-3849, 1996.
71. Chen KS, Shepel LA, Haag JD, Heil GM and Gould MN: Cloning, genetic mapping, and expression studies of the rat BRCA 1 gene. Carcinogenesis 17: 1561-1566, 1996.
72. Guerrero I and Pellicer A: Mutational activation of oncogenes, in animal model systems of carcinogenesis. Mutation Res 18: 293-308, 1987.
73. National Academy of Sciences/National Research Council (NAS): Health Effects of Exposure to Low Levels of Ionizing Radiation (BEIR IV). Washington, D.C, Natl. Acad. Press, 1990.
74. Pierce D, Shimizu Y, Preston D, Vaeth M and Mabuchi K: Studies of the mortality of atomic bomb survivors. Report 12, Part 1. Cancer: 1950-1990. Radiat Res 146: 1-27, 1996.
75. Pierce DA and Preston DL: Radiation-related cancer risk at low doses among atomic bomb survivors. Radiat Res 154: 178-186, 2000.
76. Doll R and Wakeford R: Risk of childhood cancer from fetal irradiation. Br J Radiol 70: 130-139, 1997.
77. Boice JDll Jr, Rosenstein M and Trout E: Estimation of breast doses and breast cancer risk associated with repeated fluoroscopic chest examinations of women with tuberculosis. Radiat Res 73: 373-390: 1978.
78. Ron E, Lubin J, Shore RE, Mabuchi K, Modan B, Pottern L, Schneider A, Tucker M and Boice JD: Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies. Radiat Res 141: 259-277, 1995.
79. Cardis E, Gilbert ES, Carpenter L, Howe G, Kato I, Armstrong BK, Beral V, Cowper G, Douglas A, Fix J, Fry SA, Kaldor J, Lave C, Salmon L, Smith PG, Voelz GL and Wiggs LD: Effects of low doses and low dose rates of external radiation: Cancer mortality among nuclear industry workers in three countries. Radiat Res 142: 117-132, 1995.
80. Sankaranarayanan K and Chakraborty R: Cancer predisposition, radiosensitivity and the risk of radiation-induced cancers. I. Background Radiat Res 143: 121-143, 1995.
81. International Commission on Radiological Protection (ICRP): Genetic susceptibility to cancer. Ann. ICRP 28, No. 1-2, 1998.
82. Little MP and Muirhead CR: Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. Int J Rad Biol 70: 83-94, 1996.
83. Sinclair WK: The linear no-threshold response: Why not linearity? Med Phys 25: 285-290, 1998.
84. Kondo S: Health Effects of Low-Level Radiation. Osaka, Kinki University Press, 1993.
85. Cohen BL: test of the linear-no threshold theory of radiation carcinogenesis. Health Phys 68: 157-174, 1995.
86. Patterson HW: Discontinue use of linear models. Health Phys. Newsletter Vol 23 (6): 9, 1995.
87. Pollycove M and Feinendegen LE: Molecular biology, epidemiology, and the demise of the linear no-threshold (LNT) hypothesis. CR Acad Sci Paris, Life Sciences 332: 197-204, 1999.
88. Pollycove M and Feinendegen LE: Biologic response to low doses of ionizing radiation: Detriment versus hormesis. Part 2: Dose responses of organisms. J Nucl Med 42: 26N-32N, 2001.
89. Calabrese EJ and Baldwin LA: Radiation hormesis and cancer. Human and Ecol Risk Assessment 8: 327-353, 2002.
90. Hagmar L, Brigger A, Hansteen IL, Heim S, Hogstedt B, Knudse L, Lambert B, Linnainmaa K, Mittehnan F, Nordenson I, Renterwall C, Salomaa S, Skerving S and Sorsa M: Cancer risk in hu,ams predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54: 2919-2922, 1994.
91. Wiman KG: New p5 3 -base anti-cancer therapeutic strategies. Med Oncol 15: 222-228, 1998.
92. Buchsbaum DJ and Curiel DT: Geney therapy for the treatment of cancer. Cancer Bioter Radiopharm 16: 275-288, 2001.
93. Kantoian HM, O'Brien S, Cortes JE, Smith TL, Rios MB, Shan J, Yang Y, Giles FJ, Thomas DA, Faderl S, Garcia-Manero G, Jeha S, Wierda W, Issa JP, Komblau SM, Keating M, Resta D, Capdeville R and Talpaz M: Treatment of Philadelphia-positive accelerated-phase chronic myelogenous leukemia with imatinib mesylate. J Clin Cancer Res 8: 2167-2176, 2002.
94. Krewski D, Thorsland T and Whithey J: Carcinogenic risk assessment of complex mixtures. Toxicol Ind Health 5: 851-867, 1989.
95. National Academy of Sciences, National Research Council. Science and Judgement in Risk Assessment, Washington, D.C, National Academy Press, 1994.
96. Bennett CB, Lewis LK, Karthikeyan G, Lobachev KS, Jin YH, Sterling JF, Snipe JR, and Resnick MA: Genes required for ionizing radiation resistance in yeast. Nature Genetics 29: 426-434, 2001.